Evidence map›Paper›PMID 30668585›Full record

ArticlePloS one2019

Potent, multi-target serine protease inhibition achieved by a simplified β-sheet motif.

Xingchen Chen, Blake T Riley, Simon J de Veer, David E Hoke, Jessica Van Haeften, Darren Leahy, Joakim E Swedberg, Maria Brattsand, Perry J Hartfield, Ashley M Buckle and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Xingchen ChenSchool of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Blake T RileyDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.ORCID 0000-0003-2176-0503
Simon J de VeerInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
David E HokeDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Jessica Van HaeftenSchool of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Darren LeahySchool of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Joakim E SwedbergInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
Maria BrattsandDepartment of Medical Biosciences, Umeå University, Umeå, Sweden.ORCID 0000-0001-7175-1336
Perry J HartfieldSchool of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Ashley M BuckleDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Jonathan M HarrisSchool of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.ORCID 0000-0003-4209-2380
Queensland University of Technology · AUAustralian Regenerative Medicine Institute · AUThe University of Queensland · AUUmeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Engagement of an extended β-sheet is a common substrate/inhibitor interaction at the active site of serine proteases and is an important feature of Laskowski mechanism inhibitors that present a substrate-like loop to a target protease. This loop is cleaved but subsequently relegated forming a stable inhibitor/protease complex. Laskowski inhibitors are ubiquitous in nature and are used extensively in serine protease inhibitor design. However, most studies concentrate on introducing new sidechain interactions rather than the direct contributions of the substrate-like β-sheet to enzyme inhibition. Here we report the crystal structure of an simplified β-sheet inhibitory motif within the Sunflower Trypsin Inhibitor (SFTI) in complex with trypsin. We show that the intramolecular hydrogen bond network of this SFTI variant (SFTI-TCTR) engages the inhibitor sidechains that would normally interact with a target protease, giving mainchain interactions a more prominent role in complex formation. Despite having reduced sidechain interactions, this SFTI variant is remarkably potent and inhibits a diverse range of serine proteases. Crystal structural analysis and molecular modelling of SFTI-TCTR complexes again indicates an interface dominated by β-sheet interactions, highlighting the importance of this motif and the adaptability of SFTI as a scaffold for inhibitor design.

Indexed as

Amino Acid MotifsAnimalsCattleCrystallography, X-RayHelianthusHydrogen BondingModels, MolecularMolecular Dynamics SimulationPeptides, CyclicPlant ProteinsProtein Conformation, beta-StrandProtein Interaction Domains and MotifsSerine Proteinase InhibitorsStatic ElectricityTrypsinTrypsin InhibitorsPeptides, CyclicPlant ProteinsSerine Proteinase InhibitorsTrypsinTrypsin Inhibitors

Identifiers

PMID30668585
PMCPMC6342301
OpenAlexW2914492275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.